Abstract:Three-dimensional (3D) cell culture models have been extensively utilized in various mechanistic studies as well as for drug development studies as superior in vitro platforms than conventional two-dimensional (2D) cell culture models. This is especially the case in cancer biology, where 3D cancer models, such as spheroids or organoids, have been utilized extensively to understand the mechanisms of cancer development. Recently, many sophisticated 3D models such as organ-on-a-chip models are emerging as advanced in vitro models that can more accurately mimic the in vivo tissue functions. Despite such advancements, spheroids are still considered as a powerful 3D cancer model due to the relatively simple structure and compatibility with existing laboratory instruments, and also can provide orders of magnitude higher throughput than complex in vitro models, an extremely important aspects for drug development. However, creating well-defined spheroids remain challenging, both in terms of throughputs in generation as well as reproducibility in size and shape that can make it challenging for drug testing applications. In the past decades, droplet microfluidics utilizing hydrogels have been highlighted due to their potentials. Importantly, core-shell structured gel droplets can avoid spheroid-to-spheroid adhesion that can cause large variations in assays while also enabling long-term cultivation of spheroids with higher uniformity by protecting the core organoid area from external environment while the outer porous gel layer still allows nutrient exchange. Hence, core-shell gel droplet-based spheroid formation can improve the predictivity and reproducibility of drug screening assays. This review paper will focus on droplet microfluidics-based technologies for cancer spheroid production using various gel materials and structures. In addition, we will discuss emerging technologies that have the potential to advance the production of spheroids, prospects of such technologies, and remaining challenges.

Droplet-based bioprinting for fabrication of tumor spheroids

Uniform sized cancer spheroids production using hydrogel-based droplet microfluidics: a review

Advanced tumor organoid bioprinting strategy for oncology research

The acoustic droplet printing of functional tumor microenvironments

Bioprinting of in vitro tumor models for personalized cancer treatment: a review

Spheroid On-Demand Printing and Drug Screening of Endothelialized Hepatocellular Carcinoma Model at Different Stages.

Bioprinting of 3D Breast Epithelial Spheroids for Human Cancer Models

3D Bioprinting as a Powerful Technique for Recreating the Tumor Microenvironment

Advances in tumor microenvironment: Applications and challenges of 3D bioprinting

Microfabrication methods for 3D spheroids formation and their application in biomedical engineering

High-throughput acoustofluidic fabrication of tumor spheroids.

Droplet Microfluidics for Current Cancer Research: From Single-Cell Analysis to 3D Cell Culture

Embedded bioprinted multicellular spheroids modeling pancreatic cancer bioarchitecture towards advanced drug therapy

Converging bioprinting and organoids to better recapitulate the tumor microenvironment

Three-dimensional bioprinting of in vitro tumor organoid and organ-on-a-chip models

Application of 3D cultured multicellular spheroid tumor models in tumor-targeted drug delivery system research.

High-throughput Three-Dimensional Spheroid Tumor Model Using a Novel Stamp-Like Tool.

Multidimensional Controllable Fabrication of Tumor Spheroids Based on a Microfluidic Device.

Improving Bioprinted Volumetric Tumor Microenvironments In Vitro

Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling

Bioprinting native-like 3D micro breast cancer tissues utilizing existing cancer cell lines